Sometimes a value investor - this will have a p/e of like 5 at current pps - without new product revenues.

Sometimes a growth investor. Aids is still real and uncontrolled in many parts of the world. TRIB's HIV test is a leader. I'm not expecting blowout sales of Destiny Max due to lack of news since approval, although I do feel that positive revenues will come in time. Tri-stat is another matter. I feel this could be a blockbuster!

You get the best of both worlds here. Substantiate it with a strong balance sheet and b/v to pps ratio ... no - brainer. Back up the truck! <IMO>